New data support tailoring regional nodal irradiation in patients treated with neoadjuvant chemotherapy on the basis of their ...

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab ...

A new partnership between Oceanside Unified and MiraCosta College will offer students the opportunity to earn a ...

The VERONA trial evaluated the safety and efficacy of venetoclax with azacitidine in treatment-naïve adults with higher-risk MDS.

In this video, Susana M. Campos, MD, MPH, discusses results from a phase 3 clinical trial of dostarlimab and niraparib in advanced ovarian cancer, presented at ASCO Annual Meeting.The FIRST/ENGOT-OV44 ...

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive power for drug discovery.

FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply ...